PharMerica Corp. (PMC) Stock Price Up 1.3%
Shares of PharMerica Corp. (NYSE:PMC) rose 1.3% on Friday . The company traded as high as $25.17 and last traded at $25.00, with a volume of 269,098 shares traded. The stock had previously closed at $24.67.
PMC has been the topic of a number of recent research reports. Zacks Investment Research raised shares of PharMerica Corp. from a “sell” rating to a “hold” rating in a research report on Wednesday. TheStreet downgraded shares of PharMerica Corp. from a “buy” rating to a “hold” rating in a research report on Monday, May 9th. Barrington Research reaffirmed an “outperform” rating and issued a $34.00 target price (up from $30.00) on shares of PharMerica Corp. in a research report on Tuesday, May 10th. Finally, Bank of America Corp. began coverage on shares of PharMerica Corp. in a research report on Tuesday, June 7th. They set a “buy” rating and a $32.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company’s stock. PharMerica Corp. has an average rating of “Buy” and an average price target of $31.57.
The company has a market cap of $772.48 million and a price-to-earnings ratio of 25.94. The stock’s 50-day moving average is $25.02 and its 200-day moving average is $24.63.
PharMerica Corp. (NYSE:PMC) last issued its quarterly earnings results on Tuesday, August 9th. The company reported $0.47 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.47. During the same quarter in the previous year, the firm posted $0.48 EPS. The business had revenue of $519.60 million for the quarter, compared to analysts’ expectations of $508.31 million. PharMerica Corp.’s revenue was up 4.4% on a year-over-year basis. On average, equities analysts forecast that PharMerica Corp. will post $2.01 earnings per share for the current fiscal year.
An institutional investor recently raised its position in PharMerica Corp. stock. Trexquant Investment LP boosted its position in shares of PharMerica Corp. (NYSE:PMC) by 148.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,140 shares of the company’s stock after buying an additional 18,031 shares during the period. Trexquant Investment LP owned approximately 0.10% of PharMerica Corp. worth $1,055,000 as of its most recent SEC filing.
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.